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Normal placental structure and function is essential for a
healthy pregnancy; the placenta is responsible for nutri-
ent and oxygen transport, removal of waste products,
protection from infection, modulation of the maternal
immune system and hormone production to maintain
pregnancy. The human placenta is structurally adapted
to fulfil this role as it is haemomonochorial, minimising
the distance between maternal and fetal circulations to
maximise exchange. Disorders of the placenta including:
FGR, pre-eclampsia, placental abruption and abnormal
(velamentous) cord insertion are associated with over
50% of stillbirths and are frequently cited as the primary
cause of death [1-3].
Abnormal placental structure and function significantly
increases the risk of stillbirth. Levels of pregnancy asso-
ciated plasma protein A (PAPP-A) in the lowest 5% and
alpha fetoprotein (AFP) in the highest 5% increase the
risk of stillbirth by 50-fold and 2.8-fold respectively [4,5].
In women at high-risk of pregnancy complications,
abnormal placental structure and/or blood flow seen by
ultrasound scan at 19-23 weeks preceded 15 out of 22
stillbirths [6]. There are few studies of microscopic pla-
cental structure in stillbirth. However, microscopic struc-
ture and cell turnover of the villous trophoblast are
disrupted in FGR and pre-eclampsia [7-9]. Evidence from
genetic analyses demonstrated that gene imprinting in
the placenta is altered in pregnancy loss [10]. The impor-
tance of placenta genetics and epigenetics is supported
by the observation of increased stillbirth and pregnancy
loss in confined placental mosaicism where genetic
abnormalities are only present in the placenta [11].
Due to its central role in determining pregnancy out-
come, detailed examination of the placenta can give use-
ful information about the cause of stillbirth and is
recommended by the Royal College of Obstetricians and
Gynaecologists (RCOG), American College of Obstetri-
cians and Gynecologists (ACOG) and Perinatal Society of
Australia and New Zealand (PSANZ) [12,13]. Examina-
tion of the placenta reduces the proportion of unex-
plained stillbirths [14]. Consequently, examination of
the placenta is one of the most common investigations
undertaken after a stillbirth and is one of the most
valuable [2,15].
Despite the value of placental examination to identify
conditions associated with stillbirth including: fetal
thrombotic vasculopathy, chronic intervillositis, villitis,
chorioamnionitis, funisitis, infarction, massive perivillous
fibrin deposition, villous dysmaturity (increased syncytial
knot formation), villous immaturity and cord lesions
further research is needed to increase the understanding
of placental pathology in stillbirth. This is reflected in the
research priorities for high-income countries synthesised
by an international panel of experts which mention need
for repositories of well-phenotyped samples from still-
births and from well-matched controls and the need to
understand the pathophysiological pathways in common
conditions associated with stillbirth including: diabetes,
cigarette smoking and maternal obesity [16].
An important goal of translational medicine is to use
the increased understanding of placental dysfunction to
develop improved tests of pregnancy wellbeing. For
example, factors derived from the placenta, such as
human placental lactogen or placental growth factor may
provide novel means to identify pregnancies at highest
risk of stillbirth [17]. Discovery-based technologies such
as proteomics or metabolomics offer the opportunity to
analyse biofluids and tissue in hypothesis-generating stu-
dies to provide a more holistic understanding of fetal and
placental dysfunction. Better understanding of the role of
the placenta in stillbirth offers the opportunity to develop
strategies to identify placental dysfunction in pregnan-
cies, in order that intervention may be targeted to pre-
vent stillbirth.
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